Adjuvant radiotherapy (RT) and trastuzumab in stage I-II A breast cancer: Toxicity data from North Central Cancer Treatment Group Phase III trial N9831. - Halyard,M.Y.; Pisansky,T.M.; Solin,L.J.; Marks,L.B.; Pierce,L.J.; Dueck,A.; Perez,E.A. (J Clin Oncol, 2006)